Literature DB >> 16276181

Heme oxygenase modulates small intestine leukocyte adhesion following hindlimb ischemia/reperfusion by regulating the expression of intercellular adhesion molecule-1.

Jeffrey R Scott1, Daryl K Gray, Aurelia Bihari, Amit Badhwar, Xuchen Zhang, Peiying Shan, Patty J Lee, Subrata Chakrabarti, Kenneth A Harris, Richard F Potter.   

Abstract

OBJECTIVE: Heme oxygenase is the rate-limiting enzyme in the degradation of heme into carbon monoxide, iron, and bilirubin. Recent evidence suggests that the induction of heme oxygenase-1 is associated with potent anti-inflammatory properties. The objectives of this study were to determine the temporal, regional, and cellular distribution of heme oxygenase-1 within the small intestine and its role in modulating remote intestinal leukocyte recruitment following trauma induced by hindlimb ischemia/reperfusion.
DESIGN: Randomized, controlled, prospective animal study.
SETTING: Hospital surgical research laboratory.
SUBJECTS: Male C57BL/6 mice.
INTERVENTIONS: Mice underwent 1 hr of bilateral hindlimb ischemia, followed by 3, 6, 12, or 24 hrs of reperfusion.
MEASUREMENTS AND MAIN RESULTS: Heme oxygenase-1 messenger RNA, heme oxygenase-1 protein, and heme oxygenase activity were measured using reverse transcription polymerase chain reaction, Western blot, immunohistochemistry, and spectrophotometric assay, respectively. The jejunum was also exteriorized to quantify the flux of rolling and adherent leukocytes and R-Phycoerythrin conjugated intercellular adhesion molecule-1 monoclonal antibody fluorescence intensity in submucosal postcapillary venules with the use of intravital microscopy. Ischemia/reperfusion led to a significant increase in heme oxygenase-1 messenger RNA in the jejunum and ileum 3 hrs following limb reperfusion, with a subsequent increase in heme oxygenase-1 protein and heme oxygenase activity at 6 hrs. Ischemia/reperfusion also led to a significant 1.4-fold increase in leukocyte rolling, whereas inhibition of heme oxygenase via injection of tin protoporphyrin IX (20 micromol/kg intraperitoneally) resulted in a three-fold increase in leukocyte adhesion, compared with ischemia/reperfusion alone. This increase in adhesion was significantly reduced to baseline in mice treated with intercellular adhesion molecule-1 monoclonal antibody before heme oxygenase inhibition (40 microg/mouse), whereas inhibition of heme oxygenase activity following ischemia/reperfusion also led to a significant increase in R-Phycoerythrin intercellular adhesion molecule-1 monoclonal antibody fluorescence intensity.
CONCLUSIONS: Our data suggest that remote trauma induced by hindlimb ischemia/reperfusion leads to an increase in heme oxygenase activity within the small intestine, which modulates intercellular adhesion molecule-1 dependent intestinal leukocyte adhesion.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16276181     DOI: 10.1097/01.ccm.0000186765.61268.fc

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  4 in total

Review 1.  Heme oxygenase-1 and gut ischemia/reperfusion injury: A short review.

Authors:  Yu-Feng Liao; Wei Zhu; Dong-Pei Li; Xiao Zhu
Journal:  World J Gastroenterol       Date:  2013-06-21       Impact factor: 5.742

2.  Lung endothelial HO-1 targeting in vivo using lentiviral miRNA regulates apoptosis and autophagy during oxidant injury.

Authors:  Yi Zhang; Ge Jiang; Maor Sauler; Patty J Lee
Journal:  FASEB J       Date:  2013-06-14       Impact factor: 5.191

3.  Heme oxygenase-1 deficiency promotes the development of necrotizing enterocolitis-like intestinal injury in a newborn mouse model.

Authors:  Stephanie Schulz; Ronald J Wong; Kyu Yun Jang; Flora Kalish; Karen M Chisholm; Hui Zhao; Hendrik J Vreman; Karl G Sylvester; David K Stevenson
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-04-11       Impact factor: 4.052

Review 4.  Microbiome and intestinal ischemia/reperfusion injury.

Authors:  Yuji Nadatani; Toshio Watanabe; Sunao Shimada; Koji Otani; Tetsuya Tanigawa; Yasuhiro Fujiwara
Journal:  J Clin Biochem Nutr       Date:  2018-05-25       Impact factor: 3.114

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.